Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Pharmacol Ther. 2009 May 5;123(1):105–116. doi: 10.1016/j.pharmthera.2009.04.003

Figure 2.

Figure 2

Adenosine receptor activities in the lungs of ADA-deficient mice. Genetic and pharmacologic approaches in the ADA-deficient model suggest that adenosine receptor signaling influences both tissue protective and tissue destructive pathways in the lungs.